A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation

Cell Growth and Differentiation

Volumn 13, Issue 3, 2002, Pages 115-122

  Huynh, Hung ^a   Chow, Pierce K H ^a   Ooi, London L P ^a   Soo, Khee Chee ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3' KINASE; PROTEIN SUBUNIT; RECOMBINANT SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN B; SOMATOMEDIN B ANTIBODY; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR DENSITY; TREATMENT OUTCOME; WESTERN BLOTTING;

AUTOCRINE COMMUNICATION; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER; LIVER NEOPLASMS; PARACRINE COMMUNICATION; TUMOR CELLS, CULTURED;

CERVUS ELAPHUS;

EID: 0036251946     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
2. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
3. Results of 280 liver resections for hepatocellular carcinoma
4. Primary hepatocellular cancer: Western experience
5. Hepatocellular carcinoma: The Asian experience
6. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. (Cochrane Review)
7. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)
8. Evidence of autocrine regulation in human hepatoma cell lines
9. Transcripts of the insulin-like growth factors I and II in human hepatoma
10. Expression of insulinlike growth factor II mRNA in hepatocellular carcinoma
11. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis
12. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice
13. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
14. Insulin-like growth factor binding proteins and their role in controlling IGF actions
15. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
16. Regulation of insulin-like growth factor I receptor by the pure antiestrogen ICI 182,780
17. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
18. Transforming growth factor-b-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
19. Retinoic acid inhibits growth of breast cancer cell lines: The role of insulin-like growth factor binding proteins
20. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma1070
21. Silencing of the mammary derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes
22. Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring
23. A cell cycle regulator potentially involved in genesis of many tumor types
24. Hepatocellular carcinoma: From gene to public health
25. Epidemiological characteristics and risk factors of hepatocellular carcinoma
26. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
27. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
28. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor